253 related articles for article (PubMed ID: 31104506)
1. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models.
Haanes KA; Labastida-Ramírez A; Blixt FW; Rubio-Beltrán E; Dirven CM; Danser AH; Edvinsson L; MaassenVanDenBrink A
Cephalalgia; 2019 Oct; 39(11):1421-1434. PubMed ID: 31104506
[TBL] [Abstract][Full Text] [Related]
2. Inefficient constitutive inhibition of P2X3 receptors by brain natriuretic peptide system contributes to sensitization of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine.
Marchenkova A; Vilotti S; Ntamati N; van den Maagdenberg AM; Nistri A
Mol Pain; 2016; 12():. PubMed ID: 27175010
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF.
Giniatullin R; Nistri A; Fabbretti E
Mol Neurobiol; 2008 Feb; 37(1):83-90. PubMed ID: 18459072
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide homeostasis and purinergic nociceptive signaling in rat meninges in migraine-like conditions.
Yegutkin GG; Guerrero-Toro C; Kilinc E; Koroleva K; Ishchenko Y; Abushik P; Giniatullina R; Fayuk D; Giniatullin R
Purinergic Signal; 2016 Sep; 12(3):561-74. PubMed ID: 27369815
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats.
Ma QP; Hill R; Sirinathsinghji D
Eur J Neurosci; 2001 Jun; 13(11):2099-104. PubMed ID: 11422450
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of nerve growth factor induces plasticity of ATP-sensitive P2X3 receptors of nociceptive trigeminal ganglion neurons.
D'Arco M; Giniatullin R; Simonetti M; Fabbro A; Nair A; Nistri A; Fabbretti E
J Neurosci; 2007 Aug; 27(31):8190-201. PubMed ID: 17670966
[TBL] [Abstract][Full Text] [Related]
9. Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide.
Fabbretti E; D'Arco M; Fabbro A; Simonetti M; Nistri A; Giniatullin R
J Neurosci; 2006 Jun; 26(23):6163-71. PubMed ID: 16763024
[TBL] [Abstract][Full Text] [Related]
10. Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model.
Chan KY; Gupta S; de Vries R; Danser AH; Villalón CM; Muñoz-Islas E; Maassenvandenbrink A
Br J Pharmacol; 2010 Jul; 160(6):1316-25. PubMed ID: 20590623
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 Knock-in mice: implications for basic mechanisms of migraine pain.
Ceruti S; Villa G; Fumagalli M; Colombo L; Magni G; Zanardelli M; Fabbretti E; Verderio C; van den Maagdenberg AM; Nistri A; Abbracchio MP
J Neurosci; 2011 Mar; 31(10):3638-49. PubMed ID: 21389219
[TBL] [Abstract][Full Text] [Related]
12. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
13. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system.
Limmroth V; Katsarava Z; Liedert B; Guehring H; Schmitz K; Diener HC; Michel MC
Pain; 2001 May; 92(1-2):101-6. PubMed ID: 11323131
[TBL] [Abstract][Full Text] [Related]
14. Loss of inhibition by brain natriuretic peptide over P2X3 receptors contributes to enhanced spike firing of trigeminal ganglion neurons in a mouse model of familial hemiplegic migraine type-1.
Marchenkova A; van den Maagdenberg AM; Nistri A
Neuroscience; 2016 Sep; 331():197-205. PubMed ID: 27346147
[TBL] [Abstract][Full Text] [Related]
15. The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels.
Akerman S; Williamson DJ; Kaube H; Goadsby PJ
Eur J Pharmacol; 2002 Oct; 452(2):223-8. PubMed ID: 12354573
[TBL] [Abstract][Full Text] [Related]
16. Expression and characterization of purinergic receptors in rat middle meningeal artery-potential role in migraine.
Haanes KA; Edvinsson L
PLoS One; 2014; 9(9):e108782. PubMed ID: 25265286
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine.
Stucky NL; Gregory E; Winter MK; He YY; Hamilton ES; McCarson KE; Berman NE
Headache; 2011 May; 51(5):674-92. PubMed ID: 21521205
[TBL] [Abstract][Full Text] [Related]
18. Salmon calcitonin ameliorates migraine pain through modulation of CGRP release and dural mast cell degranulation in rats.
Kilinc E; Dagistan Y; Kukner A; Yilmaz B; Agus S; Soyler G; Tore F
Clin Exp Pharmacol Physiol; 2018 Jun; 45(6):536-546. PubMed ID: 29344989
[TBL] [Abstract][Full Text] [Related]
19. Role of ATP in migraine mechanisms: focus on P2X3 receptors.
Giniatullin R; Nistri A
J Headache Pain; 2023 Jan; 24(1):1. PubMed ID: 36597043
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
Haanes KA; Edvinsson L
CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
